South America Travel Vaccines Market Forecast to 2028

Report Code : BMIRE00025527 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 10/Aug/2022
South America Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

The travel vaccines market in SAM is expected to grow from US$ 143.20 million in 2021 to US$ 243.85 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028.

The SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM. During the forecast period, the region is expected to continue its dominance due to an increase in the prevalence of regional diseases, rapid technological innovations, vaccine development, and an increasing geriatric population. Brazil is the major vaccine manufacturer in the region. The country is self-sufficient for 54% of vaccination needs, including DTP, DT for adults and infants, TT, HepB, and DTP combined vaccines (DTP-HB and DTP-HB-Hib), seasonal influenza vaccine, YF vaccine, and meningo AþC. Brazil is one of the major worldwide producers of the YF vaccine, with the lowest market price. Similar to Brazil, Argentina is also the largest country in the region. Argentina has an upper middle-income economy with a diversified industrial sector. The country’s GDP was US$ 123,369 million in 2021. The GDP of Argentina has grown at a compound rate of 6.8% over the last five years. Major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the growth of the market. The factors such as increasing focus on vaccine research, continuous advancements in vaccine development technologies, and increasing government spending on pharmaceutical R&D in the region are expected to boost the travel vaccines market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM travel vaccines market. The SAM travel vaccines market is expected to grow at a good CAGR during the forecast period.

SAM Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

SAM Travel Vaccines Market Segmentation

SAM travel vaccines market is segmented into product, application, and country. The SAM travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The SAM travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM.

Abbott; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.

The List of Companies - South America Travel Vaccines Market

● Abbott

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Travel Vaccines Market – By Product

1.3.2 SAM Travel Vaccines Market – By Application

1.3.3 SAM Travel Vaccines Market – By Country

2. SAM Travel Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Travel Vaccines Market– Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Expert Opinion

5. SAM Travel Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Travel and Tourism is Growing

5.1.2 Growing Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 High Cost of Travel Vaccines

5.3 Market Opportunities

5.3.1 Awareness Regarding Vaccines

5.4 Future Trends

5.4.1 Continuous Ongoing Demand for Vaccines

5.5 Impact Analysis

6. Travel Vaccines Market – SAM Analysis

6.1 SAM Travel Vaccines Marker Revenue Forecast and Analysis

7. SAM Travel Vaccines Market Analysis – By Product

7.1 Overview

7.2 SAM Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3 Hepatitis A

7.3.1 Overview

7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Hepatitis B

7.4.1 Overview

7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5 Meningococcal Vaccines

7.5.1 Overview

7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8. SAM Travel Vaccines Market Analysis – By Application

8.1 Overview

8.2 SAM Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3 Domestic Travel

8.3.1 Overview

8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Outbound Travel

8.4.1 Overview

8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9. SAM Travel Vaccines Market – Country Analysis

9.1 Overview

9.1.1 SAM: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1 Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1 Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2 Brazil: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3 Brazil: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2 Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1 Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2 Argentina: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3 Argentina: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3 Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1 Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2 Rest of SAM: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3 Rest of SAM: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10. Travel Vaccines Market–Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Travel Vaccines Market, (%)

10.3 Organic Developments

10.3.1 Overview

10.4 Inorganic Developments

10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Merck & Co., Inc.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Sanofi

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Novartis AG

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Abbott

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

12. Appendix

12.1 About the Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Brazil: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             Brazil: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Argentina: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Argentina: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Rest of SAM: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Rest of SAM: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Organic Developments Done by Companies

Table 8.             Inorganic Developments Done by Companies

Table 9.             Glossary of Terms, SAM Travel vaccines Market

The List of Companies - South America Travel Vaccines Market

● Abbott

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM travel vaccines market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM travel vaccines market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the travel vaccines market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(South America Travel Vaccines Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry